Endocrine Abstracts

HIV-1-infected patients under antirretroviral treatment develop the so-called ‘lipodystrophy syndrome’. It is characterized by peripheral lipoatrophy (face, limbs), visceral lipohypertrophy, and, sometimes abnormal accumulation of subcutaneous fat in specific sites, especially the dorso-cervical area. The abnormal fat distribution is associated with systemic alterations characteristic of the metabolic syndrome (dyslipidemia, insulin resistance). Drugs are importantly...